INTRODUCTION
============

The 22q11.2 deletion syndrome (22q11.2DS), also known as the velocardiofacial/DiGeorge syndrome, is a phenotypically heterogenous disease which is caused by a hemizygous microdeletion on the long arm of chromosome 22 in the region q11.2. The overall prevalence is 1 in 2,000--4,000 live births ([@B87]; [@B11]; [@B104]). The disorder is associated with a high risk for psychiatric disorder.

In particular, 22q11.2DS patients have an estimated 20--25% risk for schizophrenia or related psychotic disorders such as schizoaffective disorder ([@B87]; [@B23]; [@B5]; [@B98]). The deletion is therefore the strongest known genetic risk factor for schizophrenia (odds ratio = 20.3; [@B72]), and accounts for approximately 1--2% of all schizophrenia cases ([@B61], [@B62]; [@B5]; [@B55]; [@B124]). Individuals with 22q11.2DS have variable cognitive and behavioral deficits ([@B62]) including relative impairments in social judgment, motor skills, verbal learning, and executive functioning ([@B23]; [@B98]). In addition, adults with a 22q11.2 microdeletion have a two- to threefold increase in the risk of generalized anxiety disorder compared to the general population ([@B98]). The major clinical features of 22q11.2DS-related schizophrenia are largely indistinguishable from those of the idiopathic disease ([@B87]; [@B23]; [@B5]). Identification of schizophrenia-risk gene/s in the 22q11.2DS deletion region may therefore generate insights into the pathophysiology of schizophrenia in general ([@B34]).

The size of the 22q11.2 deletion varies. The majority of 22q11.2 deletions (around 90%) are 3 Mb in size and span approximately 60 known genes, while the remaining 10% are 1.5 Mb in size and encompass around 35 genes ([@B36]; [@B116]). Both the larger and the smaller 22q11.2 microdeletions usually result from non-allelic homologous recombination, which is mediated by flanking low-copy repeats ([@B36]). Although the 22q11.2DS phenotype is highly variable, its severity is not correlated with the size of the deletion. This suggests that the minimal 1.5 Mb deletion region is crucial in terms of etiology ([@B13]; [@B62]).

Initial research to identify schizophrenia-risk genes in the 22q11.2 deletion region proved unsuccessful. The identification of heterozygous loss-of-function mutations in non-deleted schizophrenia patients would be the most obvious human genetic evidence for the involvement of a specific gene in disease susceptibility. Hopes were raised by the identification of heterozygous point mutations in the T-box 1 gene (*TBX1*), which encodes a T-box transcription factor, that resulted in the characteristic abnormal facies and cardiac defects of 22q11.2DS in patients without a 22q11.2 deletion ([@B139]; [@B150]). However, no such mutation has yet been identified in schizophrenia patients.

In contrast, recent research in the *Df(16)A*^+/-^ mouse model has generated breakthroughs in our understanding of the underlying biological mechanisms of 22q11.2DS schizophrenia-risk. This engineered mouse strain carries a heterozygous chromosomal deletion which spans a segment syntenic to the human 22q11.2 locus. *Df(16)A*^+/-^ mice show deficits in the synaptic connectivity of hippocampal neurons, including a lower density of dendritic spines and glutamatergic synapses ([@B86]). In addition, *Df(16)A*^+/-^ mice display hyperactive behavior and deficits in spatial working memory-dependent learning ([@B123]). Further characterization of this animal model has suggested that the 22q11.2 microdeletion results in alterations in the biogenesis of brain microRNAs ([@B123]; [@B138]). Primary candidate genes in the region are the DiGeorge syndrome critical region gene 8 (*DGCR8*), which encodes a component of the microprocessor complex essential for microRNA biogenesis ([@B129]), and the *MIR185* gene ([@B62]), which encodes microRNA 185. Both genes are located within the minimal 1.5 Mb deletion region at 22q11.2 ([@B62]).

The microRNAs are a class of 21--25-nucleotide small non-coding RNAs. They control the expression of their target genes by binding to target sites in messenger RNAs (mRNAs), typically in their 3′ untranslated regions ([@B50]; [@B83]). In most cases, microRNAs negatively regulate target gene expression through a combination of repression of mRNA translation and promotion of mRNA decay. Each microRNA usually controls up to several hundred target mRNAs, while one mRNA target can be synergistically regulated by multiple microRNAs ([@B108]; [@B31]; [@B33]). This allows microRNAs to integrate different intracellular signals and to regulate various signaling pathways ([@B60]; [@B22]). Accumulating evidence suggests that microRNAs contribute to the basic mechanisms underlying brain development and plasticity (**Table [1](#T1){ref-type="table"}**; [@B40]; [@B112]; [@B53]). Neural microRNAs play an important role at various stages of synaptic development, including dendritic arborization ([@B132]; [@B143]), synapse formation, and synapse maturation ([@B14]; [@B119]). Arguably the two most extensively studied examples in the context of synapse development are *miR-132* and *miR-134*. CREB-induced *miR-132* promotes dendritogenesis and spine growth by down-regulating p250GAP ([@B134]; [@B78]). *miR-134* on the other hand is required for activity-dependent dendritic arborization and the restriction of spine growth by targeting Pumilio-2 and Lim-domain containing protein kinase (Limk1), respectively ([@B113]; [@B41]). Furthermore, investigation of a mouse model displaying conditional knock-out of the microRNA biogenesis enzyme *Dicer* ([@B112]) revealed disrupted morphogenesis of the hippocampus and cortex ([@B26]), suggesting that undisturbed microRNA processing might be necessary for normal brain development ([@B138]). These data suggest the possible involvement of microRNA-dependent dysregulation in the pathogenesis of various psychiatric disorders ([@B42]; [@B138]), including schizophrenia ([@B8]).

###### 

List of individual microRNAs involved in neural development and synapse development/plasticity and their mRNA targets in mice and men.

  MicroRNA                                                   Function                                                                                                                                                                                                               Target/s                                            Reference
  ---------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------- ----------------------------------------------------------------------------------------------
  **microRNAs involved in neural development**                                                                                                                                                                                                                                                                                          
  let-7                                                      Promotes neuronal differentiation                                                                                                                                                                                      HMGA, LIN28, TLX                                    [@B89], [@B105], [@B147]
                                                             Neural tube closure                                                                                                                                                                                                    MLIN41                                              [@B80]
  miR-7a                                                     Inhibits differentiation of forebrain dopaminergic neurons                                                                                                                                                             PAX6                                                [@B28]
  miR-9                                                      Promotes neuronal differentiation                                                                                                                                                                                      FOXG1, TLX, STAT3, REST, FGF8, FGFR1, FOXP2         [@B66], [@B71], [@B95], [@B7],[@B8], [@B148], [@B142], [@B24]
                                                             Promotes proliferation of early human embryonic stem cell-derived neural progenitor cells                                                                                                                              STMN1                                               [@B29]
  miR-9\*                                                    Promotes neuronal differentiation                                                                                                                                                                                      BAF53a                                              [@B1],[@B2]
                                                             ?                                                                                                                                                                                                                      coREST                                              [@B95]
  miR-17                                                     Inhibits neural differentiation                                                                                                                                                                                        ?                                                   [@B9]
  miR-17/92                                                  Promotes axonal outgrowth in embryonic cortical neurons                                                                                                                                                                PTEN                                                [@B146]
                                                             Controls spinal neural progenitor patterning                                                                                                                                                                           Olig2                                               [@B16]
  miR-34a                                                    Antagonizes neuronal differentiation                                                                                                                                                                                   Numbl                                               [@B39]
                                                             Promotes neuroblastoma and medulloblastoma differentiation                                                                                                                                                             ?                                                   [@B3], [@B27]
  miR-92b                                                    Limits the production of intermediate cortical progenitors                                                                                                                                                             ?                                                   [@B91]
  miR-124                                                    Promotes neuronal differentiation                                                                                                                                                                                      SCP1, PTBP1, SOX9, DLX2, JAG1, BAF53a, RhoG, Lhx2   [@B79], [@B131], [@B19], [@B1],[@B2], [@B107], [@B4], [@B43]
  miR-125                                                    Promotes neuronal differentiation                                                                                                                                                                                      GLI1, SMO, LIN28, SMAD4                             [@B38], [@B105], [@B10]
  miR-128                                                    Inhibits NSC proliferation                                                                                                                                                                                             BMI1                                                [@B46]
  miR-132                                                    Promotes synaptic integration and survival of newborn dentate gyrus and olfactory bulb neurons                                                                                                                         Nurr1, FoxP2                                        [@B77], [@B24], [@B96]
                                                             Promotes differentiation of dopamine neurons                                                                                                                                                                           Nurr1                                               [@B140]
  miR-133b                                                   Modulates maturation of dopaminergic neurons                                                                                                                                                                           PITX3                                               [@B65]
  miR-137                                                    Promotes neural differentiation of embryonic stem cells                                                                                                                                                                Klf4, Tbx3                                          [@B58]
  miR-200                                                    Promotes olfactory progenitor differentiation                                                                                                                                                                          SOX2, ETF3                                          [@B21], [@B97]
  miR-324-5p                                                 Promotes neuronal differentiation                                                                                                                                                                                      GLI1, SMO                                           [@B38]
  miR-326                                                    Promotes neuronal differentiation                                                                                                                                                                                      GLI1, SMO                                           [@B38]
  miR-541                                                    Promotes neurite outgrowth of PC12 cells                                                                                                                                                                               Synapsin-1                                          [@B145]
  **microRNAs involved in synapse development/plasticity**                                                                                                                                                                                                                                                                              
  miR-29a/b                                                  Inhibits spine maturation                                                                                                                                                                                              Arpc3                                               [@B73]
  miR-34c                                                    Negative constraint of memory consolidation                                                                                                                                                                            SIRT1                                               [@B149]
  miR-124                                                    Regulates neuronal process complexity                                                                                                                                                                                  RhoG, Cdc42                                         [@B143], [@B43]
  miR-125a                                                   Reduces number of branched spines                                                                                                                                                                                      PSD-95                                              [@B85]
  miR-125b                                                   Negatively regulates spine morphology                                                                                                                                                                                  NR2A                                                [@B35]
  miR-129                                                    Reduces intrinsic neuronal excitability                                                                                                                                                                                Kv1.1                                               [@B122]
  miR-132                                                    Promotes dendritogenesis Promotes spine growth Facilitates memory acquisition Positively regulates LTP Essential for experience-dependent plasticity in visual cortex Negatively regulates circadian clock resetting   P250RhoGap, MeCP2, RFX4                             [@B132], [@B18], [@B134], [@B35], [@B54], [@B82], [@B128], [@B115], [@B49], [@B102], [@B133]
  miR-134                                                    Necessary for activity-dependent dendritogenesis                                                                                                                                                                       Pum2                                                [@B41]
                                                             Restricts spine growth                                                                                                                                                                                                 Limk1                                               [@B113]
                                                             Interferes with memory formation and LTP                                                                                                                                                                               Creb1                                               [@B45]
  miR-137                                                    Inhibits dendritic morphogenesis                                                                                                                                                                                       Mib1                                                [@B120]
  miR-138                                                    Negatively regulates dendritic spine size                                                                                                                                                                              Apt-1                                               [@B119]
                                                             Represses axon regeneration                                                                                                                                                                                            SIRT1                                               [@B74]
  miR-146a                                                   Inhibits AMPAR endocytosis                                                                                                                                                                                             MAP1B                                               [@B17]
  miR-181a                                                   Reduces AMPAR expression and spine formation                                                                                                                                                                           GluA2                                               [@B106]
  miR-188                                                    Controls dendritic plasticity                                                                                                                                                                                          Nrp-2                                               [@B69]
  miR-219                                                    Regulates circadian clock length                                                                                                                                                                                       SCOP                                                [@B18]
  miR-375                                                    Reduces dendrite density                                                                                                                                                                                               HuD                                                 [@B1]
  miR-483-5p                                                 Rescues dendritic spine defects in MeCP2-overexpressing neurons                                                                                                                                                        MeCP2                                               [@B48]
  miR-485                                                    Regulates presynaptic homeostatic plasticity                                                                                                                                                                           Synapsin-1                                          [@B25]

NSC, neural stem cell; LTP, long-term potentiation; ? -- unknown.

The present review summarizes the various lines of evidence implicating microRNAs as the causal factor for schizophrenia in 22q11.2DS carriers and emerging evidence from expression studies and genome-wide association studies (GWAS) that these mechanisms may also be involved in the development of idiopathic schizophrenia.

THE ROLE OF *DGCR8*
===================

Investigation of *Dgcr8*^+/-^ mice confirmed that heterozygous *Dgcr8* deficiency was responsible for the reduced biogenesis of microRNAs observed in *Df(16)A*^+/-^ mice ([@B123]; [@B111]). *Dgcr8*^+/-^ mice displayed 22q11.2DS-associated cognitive and behavioral deficits, and altered short-term plasticity in the prefrontal cortex (PFC; [@B123]). This indicates that *DGCR8* heterozygosity, and the resulting alterations in microRNA expression, are sufficient to produce some of the neural deficits observed in 22q11.2DS ([@B111]). On the neuronal cell level, *Dgcr8* deficiency resulted in structural changes in dendritic spines and reduced dendritic complexity in the hippocampus ([@B123]). [@B111] identified alterations in the electrical properties of layer V pyramidal neurons in the medial PFC of *Dgcr8*^+/-^ mice, as well as a decrease in the complexity of the basal dendrites and reduced excitatory synaptic transmission. These functional results suggest that precise microRNA expression is critical for the development of PFC circuitry ([@B111]), circuitry which has been reported to be altered in schizophrenia patients ([@B130]).

*Dgcr8*^+/-^ mice also displayed a decrease in the number of cortical neurons, structural deficits in dendritic spines in the PFC, and alterations in synaptic potentiation and short-term plasticity ([@B37]). These alterations might influence functional connectivity ([@B114]), and could be implicated in the observed cognitive and behavioral deficits. In particular, they may explain observed alterations in prepulse inhibition ([@B123]), which have also been reported in schizophrenia patients ([@B99]).

[@B94] showed that heterozygous *Dgcr8* deficiency in mice led to reduced progenitor cell proliferation and neurogenesis in the adult hippocampus. This is of particular interest since alterations in the anatomy, histology, and function of the hippocampus have been consistently reported in schizophrenia patients ([@B127]). Several schizophrenia-associated genes were down-regulated in the hippocampus of *Dgcr8*^+/-^ mice ([@B94]), including the insulin-like growth factor 2 (IGF2), which was recently found to play a crucial role in hippocampal functions such as memory consolidation and fear extinction ([@B2]; [@B15]). Interestingly, restoration of IGF2 expression in the hippocampus rescued the observed spatial working memory deficits in *Dgcr8*^+/-^ mice, suggesting that IGF2 contributes -- at least in part -- to the learning and spatial working memory deficits that are associated with 22q11.2DS-related schizophrenia ([@B94]).

The question now arises as to which specific microRNAs are regulated by *DGCR8*. The investigation of *Dgcr8*^+/-^ mice identified 59 down-regulated microRNAs in the PFC and 30 down-regulated microRNAs in the hippocampus ([@B123]). These down-regulated microRNAs include *miR-185*, which is also located in the minimal 1.5 Mb deletion region at 22q11.2.

THE ROLE OF *MIR185*
====================

Studies of 22q11.2DS mouse models have identified *miR-185* as the top-scoring down-regulated microRNA in schizophrenia-associated brain areas ([@B123]; [@B6]). A recent study by [@B137] confirmed the drastic reduction in *miR-185* expression levels in the hippocampus and PFC of *Df(16)A*^+/-^ mice, and showed that this reduction contributed to deficits in dendritic complexity and spine development in hippocampal neurons. In addition, *Dgcr8* deficiency resulted in an approximately 20% reduction in *miR-185* expression in the hippocampus ([@B137]). This suggests that the pronounced reduction of *miR-185* expression in *Df(16)A*^+/-^ mice -- a reduction which is much more pronounced than would be expected by the 50% decrease in gene dosage -- may be due to the combined effect of the hemizygosity of the *MIR185* gene and the impaired maturation of the *pri-miR-185* transcript secondary to reduced *Dgcr8* levels (**Figure [1](#F1){ref-type="fig"}**; [@B137]). The large reduction in *miR-185* expression renders *miR-185* unique among the genes that are affected by the 22q11.2 microdeletion ([@B137]).

![**Dysregulation of microRNA biogenesis in 22q11.2DS animal models.** The *MIR185* and the *DGCR8* genes are located within the minimal 1.5 Mb microdeletion region on chromosome 22q11.2 and the equivalent region of mouse chromosome 16. The microdeletion leads to a hemizygosity of *MIR185* and *DGCR8*. The heterozygous *Dgcr8* deficiency is responsible for the reduced biogenesis of a specific subset of microRNAs (red) observed in *Df(16)A*^+/-^ mice ([@B123]). These down-regulated microRNAs include *miR-185* (black). The pronounced reduction of *miR-185* expression (indicated by a broader arrow) may be due to a combined effect of the hemizygosity of the *MIR185* gene and the impaired maturation of the *pri-miR-185* transcript secondary to reduced *Dgcr8* levels ([@B137]). The resulting alterations in mature microRNA expression levels may lead to altered gene expression of target genes, which might produce some of the neural, cognitive, and behavioral deficits observed in 22q11.2DS. miRISC, microRNA-induced silencing complex.](fnmol-06-00047-g001){#F1}

A recent human study confirmed a down-regulation of *MIR185* expression to 0.4× normal levels in the peripheral blood of patients with 22q11.2DS ([@B30]). This finding suggests that pronounced *miR-185* down-regulation also occurs in patients with 22q11.2DS.

Previous research has shown that *MIR185* is present or enriched in synapses ([@B76]; [@B34]). This may indicate that *MIR185* is of relevance to neural function, since a number of microRNAs have been shown to play a critical role in synaptic plasticity ([@B112]).

[@B34] identified *MIR185* as a regulator of sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA2) which maintains Ca^2+^ levels in the endoplasmatic reticulum. The depletion of *MIR185* contributes to SERCA2 upregulation and has been proposed as a mechanism leading to abnormal hippocampal synaptic plasticity in 22q11.2DS mouse models. The microRNA regulation of SERCA2 translation may also be implicated in the elevation of SERCA2 protein observed in the post-mortem brains of idiopathic schizophrenia patients ([@B34]). These results suggest that microRNA-mediated SERCA2 upregulation at central synapses might be a mechanistic link between 22q11.2DS and idiopathic schizophrenia ([@B34]).

Further support for the involvement of *MIR185* in schizophrenia is provided by findings that two of its validated targets (RhoA, Cdc42; [@B75]) are associated with altered expression levels in schizophrenia ([@B51]; [@B52]). Cdc42 (cell division cycle 42) is a member of the RhoGTPase family ([@B51]) and promotes dendritic spine formation ([@B56]; [@B126]; [@B135]) by regulating the polymerization of the actin cytoskeleton into filopodia ([@B90]). Cdc42 is activated by Collybistin/ARHGEF9 ([@B101]; [@B100]), which has recently been identified as a candidate blood biomarker in psychosis ([@B67]). RhoA (Ras homologous member A) also belongs to the RhoGTPase family and regulates the destabilization of the actin cytoskeleton ([@B51]). The activation of RhoA leads to a reduction in the number of dendritic branches and the density of dendritic spines ([@B88]; [@B51]).

EXPRESSION OF microRNAs IN IDIOPATHIC SCHIZOPHRENIA
===================================================

Post-mortem studies of human brain tissue have revealed alterations in microRNA expression in patients with schizophrenia. This research is reviewed elsewhere ([@B7]). Briefly, numerous microRNAs have been implicated in the disorder across multiple studies, including 16 microRNAs with increased and 11 microRNAs with decreased expression ([@B7]). Of particular interest in the context of the present review is the study by [@B84]. This reported a significant overlap between microRNAs dysregulated in human post-mortem brain tissue and microRNAs previously found to be altered in the PFC of a 22q11.2DS mouse model ([@B123]; [@B84]). This finding supports the hypothesis that findings in 22q11.2DS might be of relevance to idiopathic schizophrenia ([@B12]).

GWAS OF IDIOPATHIC SCHIZOPHRENIA
================================

The involvement of microRNA-dependent dysregulation in schizophrenia is supported by the results of the large GWAS of schizophrenia performed by the [@B110]. In total 17,836 patients and 33,859 controls were investigated. A single-nucleotide polymorphism (SNP) in an intron of *MIR137* was the second strongest finding (odds ratio = 1.12). Four other loci with genome-wide significance in this study contained predicted targets of *MIR137* (*TCF4*, *CACNA1C*, *CSMD1*, *C10orf26*). All four genes have recently been validated as *miR-137* targets ([@B68]).

The miRanda database lists 5,487 genes as targets of *miR-137* ([@B59]). Interestingly, *ZNF804A* is listed as a validated target ([@B63]). This gene has shown strong association with schizophrenia in previous studies ([@B92]; [@B136]). Other promising targets include the ubiquitin ligase Mind bomb one (Mib1; [@B120]) which plays an important role in neurogenesis and neurodevelopment ([@B57]; [@B20]; [@B93]).

Research in post-mortem brain samples suggests that the functional effect of the *miR-137* risk allele may result in a reduced *miR-137* expression ([@B47]). Further down-stream this may be responsible for the reduced white matter integrity, smaller hippocampi, and larger lateral ventricles observed in schizophrenia patients with the *miR-137* risk genotype ([@B70]).

CONCLUSION AND OUTLOOK
======================

Strong evidence suggests that microRNA dysregulation is implicated in the development of schizophrenia in 22q11.2DS patients. This is consistent with the growing recognition of microRNAs as important regulators of gene expression. As microRNAs integrate different intracellular signals and regulate various signaling pathways ([@B60]; [@B22]), the dysregulation of specific microRNAs could lead to the heterogenous phenotype observed in 22q11.2DS.

As summarized above, emerging evidence from expression and genetic analyses suggests that the same microRNA-regulated pathways may also play a role in idiopathic schizophrenia. However, despite a number of systematic investigations of genes in the 22q11.2DS region and the ever increasing number of GWAS data sets ([@B62]; [@B125]), no genetic study to date has identified common variation in *DGCR8* or *MIR185* as a risk factor for schizophrenia. This may simply reflect a lack of common functional variants at these loci. This hypothesis is supported by a recent study of genetic regulation of microRNA expression ([@B44]). [@B44] systematically investigated the relationship between microRNA expression levels (as quantitative traits) and common genetic variation. In this study, no SNP had significant *cis* effects on *miR-185* expression. A small number of SNPs have been reported to have significant *cis* effects on *DGCR8* expression in human monocytes ([@B144]), and fibroblasts ([@B32]). However, these associations might be tissue-specific, since a recent study of five different human post-mortem brain regions failed to identify any SNP with significant cis effects on *DGCR8* expression ([@B64]).

A challenge for future research will be to identify and validate the target genes that are affected by microRNA dysregulation and their respective pathways in a more comprehensive manner ([@B33]). Such research will improve our understanding of how alterations in microRNA-regulated genetic networks contribute to the pathophysiology of both 22q11.2DS-related and idiopathic schizophrenia.

Idiopathic schizophrenia is a multifactorial disorder for which both genetic and environmental factors exert an impact on disease susceptibility ([@B109]). However, very few data are available concerning the influence of environmental factors on microRNA dysregulation. Recent studies in mice showed that environmental factors such as stress resulted in alterations of microRNA expression in the frontal cortex ([@B103]). Future studies are therefore warranted to investigate the extent to which environmental factors are associated with microRNA dysregulation in schizophrenia.

Further research into the precise role of microRNAs in schizophrenia is important clinically, since modification of microRNA dysregulation would represent a novel therapeutic approach to this devastating and chronic disease. MicroRNAs are excellent candidates for therapy since they regulate multiple targets in various signaling pathways, thereby minimizing the risk of resistance development or compensatory mechanisms ([@B121]). This view is supported by several recent studies and reviews, which have highlighted microRNAs as promising pharmacological targets in the treatment of complex diseases such as psychiatric disorders ([@B53]), cancer ([@B121]), and diabetes ([@B81]).
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